Olanzapine by Neurelis for Bipolar Disorder (Manic Depression): Likelihood of Approval

Olanzapine is under clinical development by Neurelis and currently in Phase I for Bipolar Disorder (Manic Depression).

Jun 18, 2024 - 04:00

Olanzapine is under clinical development by Neurelis and currently in Phase I for Bipolar Disorder (Manic Depression).

Read the original article

Tags:

Previous Article

Can supermarket pharmacies plug urgent healthcare gaps?

Omalizumab biosimilar by Teva Pharmaceutical Industries for Chronic Urticaria Or...

What's Your Reaction?

0

Like

0

Dislike

0

Love

0

Funny

0

Angry

0

Sad

0

Wow

Related Posts

Opinion: A roadmap for making over-the-counter birth control affordable

Opinion: A roadmap for making over-the-counter birth co...

Aug 23, 2023

ASCO 2024: Verastem’s combo therapy for pancreatic cancer hits early trial success

ASCO 2024: Verastem’s combo therapy for pancreatic canc...

May 25, 2024

Novartis acquires Chinook for $3.2bn to boost kidney disease pipeline

Novartis acquires Chinook for $3.2bn to boost kidney di...

Aug 14, 2023